MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
TPVG stock logo

TPVG

TriplePoint Venture Growth BDC Corp.

$5.09
0.19
 (3.88%)
Exchange:  NYSE
Market Cap:  206.1M
Shares Outstanding:  9.87M
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Financial Services
Industry:  Asset Management
   
CEO:  James Peter Labe
Full Time Employees: 
Address: 
2755 Sand Hill Road
Menlo Park
CA
94025
US
Website:  https://www.tpvg.com
TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company’s total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2025/05/07 — Q1 quarter 2025

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue5,97071,18797,209
Gross Profit-27,06945,53281,180
EBITDA-39,82132,04675,727
Operating Income-39,82132,04675,727
Net Income-39,82132,04649,207

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets978,825763,040839,649
Total Liabilities632,519417,353486,028
Total Stockholders Equity346,306345,687353,621
Total Debt607,896398,827469,080
Cash and Cash Equivalents153,32845,89920,364

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow106,148152,921-57,033
Capital Expenditure000
Free Cash Flow106,148152,921-57,033
Net Income-39,82100
Net Change in Cash112,322-92,855-31,360

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2028Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)87,141.950Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)87,180.650Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)87,161.300Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)-189.180Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)-189.096Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)-189.138Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)24,627.969Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)28,122.314Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)26,300Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)39,269.742Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)39,287.182Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)39,278.462Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)0.650Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)0.700Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)0.610Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)1Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)1Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
75.633M  ?P/S
 (TTM)
: 
2.51
?Net Income
 (TTM)
: 
32.046M  ?P/E
 (TTM)
: 
4.64
?Enterprise Value
 (TTM)
: 
677.491M  ?EV/FCF
 (TTM)
: 
18.51
?Dividend Yield
 (TTM)
: 
0.18  ?Payout Ratio
 (TTM)
: 
1.34
?ROE
 (TTM)
: 
0.14  ?ROIC
 (TTM)
: 
0.07
?Net Debt
 (TTM)
: 
320.1M  ?Debt/Equity
 (TTM)
: 
1.33
?P/B
 (TTM)
: 
0.65  ?Current Ratio
 (TTM)
: 
0

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
5.25Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MARKETSnap estimates TPVG intrinsic value between $24.70 – $57.55 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate TPVG Intrinsic Value

Common questions about TPVG valuation

Is TriplePoint Venture Growth BDC Corp. (TPVG) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for TriplePoint Venture Growth BDC Corp. (TPVG) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is TPVG a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether TPVG trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is TPVG’s P/E ratio?

You can see TPVG’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for TPVG?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is TPVG a good long-term investment?

Whether TPVG fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

TPVG

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

3.88
MARKETSnap

Trading Metrics:

Open: 4.83   Previous Close: 4.9
Day Low: 4.81   Day High: 5.09
Year Low: 4.48   Year High: 7.53
Price Avg 50: 5.44   Price Avg 200: 6.14
Volume: 540184   Average Volume: 496127

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

Financial Review: TriplePoint Venture Growth BDC (NYSE:TPVG) & Saratoga Investment (NYSE:SAR)
06-04-2026 01:40
Financial Review: TriplePoint Venture Growth BDC (NYSE:TPVG) & Saratoga Investment (NYSE:SAR)
TriplePoint Venture Growth BDC Corp. (TPVG) Q4 2025 Earnings Call Transcript
04-03-2026 21:22
TriplePoint Venture Growth BDC Corp. (TPVG) Q4 2025 Earnings Call Transcript
TriplePoint Venture Growth (TPVG) Misses Q4 Earnings and Revenue Estimates
04-03-2026 19:15
TriplePoint Venture Growth (TPVG) Misses Q4 Earnings and Revenue Estimates
TriplePoint Venture Growth: SaaS Exposure And Other Challenges Ahead For 16% Yielder
09-02-2026 13:07
TriplePoint Venture Growth: SaaS Exposure And Other Challenges Ahead For 16% Yielder
TriplePoint Venture Growth BDC Corp. (NYSE:TPVG) Receives Consensus Rating of “Reduce” from Analysts
31-12-2025 01:48
TriplePoint Venture Growth BDC Corp. (NYSE:TPVG) Receives Consensus Rating of “Reduce” from Analysts
TriplePoint Venture Growth: Q3 Earnings Reinforce Structural Improvements
02-12-2025 13:18
TriplePoint Venture Growth: Q3 Earnings Reinforce Structural Improvements

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read